Cargando…
COVID-19-induced coagulopathy: Experience, achievements, prospects
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological changes (increased D-dimer [DD], prolonged activated partial thromboplastin clotting time [APTT] and prothrombin time [PT], hig...
Autores principales: | Dubey, Leonid, Dorosh, Olga, Dubey, Nataliya, Doan, Svitlana, Kozishkurt, Olena, Duzenko, Oleksandr, Kozlova, Olena, Ievtukh, Veronika, Ladny, Jerzy R., Pruc, Michal, Szarpak, Lukasz, Pukach, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287077/ https://www.ncbi.nlm.nih.gov/pubmed/36588310 http://dx.doi.org/10.5603/CJ.a2022.0123 |
Ejemplares similares
-
Heart inflammation risk after COVID-19 vaccine
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
Post-COVID-19 postural orthostatic tachycardia syndrome
por: Savytskyi, Ivan Volodymyrovych, et al.
Publicado: (2022) -
Treatment prospects for post-COVID-19 cardiac patients
por: Pruc, Michal, et al.
Publicado: (2022) -
Genesis of arrhythmia in the course of COVID-19
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis
por: Fialek, Bartosz, et al.
Publicado: (2022)